After scoring limited FDA nod, Sage and Biogen call an audible on pricing strategy for Zurzuvae
7th November 2023 Uncategorised 0 After scoring limited FDA nod, Sage and Biogen call an audible on pricing strategy for Zurzuvae
kdunleavy
Tue, 11/07/2023 – 14:56
More: After scoring limited FDA nod, Sage and Biogen call an audible on pricing strategy for Zurzuvae
Source: fierce